MARKET

GTBP

GTBP

Gt Biopharma Inc
NASDAQ
0.5389
+0.0424
+8.54%
Closed 19:53 02/06 EST
OPEN
0.4800
PREV CLOSE
0.4965
HIGH
0.5400
LOW
0.4548
VOLUME
989.20K
TURNOVER
0
52 WEEK HIGH
3.850
52 WEEK LOW
0.4011
MARKET CAP
14.36M
P/E (TTM)
-0.1596
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GTBP last week (0202-0206)?
Weekly Report · 2h ago
BUZZ-U.S. STOCKS ON THE MOVE-Allurion, Rithm Capital, Medtronic
Reuters · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-Western Digital, Broadridge, WTW
Reuters · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-JetBlue, VSE, Walt Disney
Reuters · 5d ago
BUZZ-GT Biopharma surges as FDA clears human trial for new cancer drug
Reuters · 5d ago
GT Biopharma Receives FDA Clearance Of Investigational New Drug Application For GTB-5550 TriKE
Benzinga · 5d ago
GT Biopharma erhält FDA-Zulassung für IND-Antrag zu GTB-5550
Reuters · 5d ago
GT Biopharma Receives FDA Clearance for IND Application of GTB-5550 TriKE
Reuters · 5d ago
More
About GTBP
GT Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapeutic products based on its proprietary Tri-specific Killer Engager (TriKE) natural killer (NK) cell engager platform. Its TriKE platform is designed to harness and enhance the cancer-killing abilities of a patient’s immune system’s natural killer cells. Its product candidate pipeline includes GTB-3550, GTB-3650, GTB-5550, GTB-7550, GTB-6550, GTB-1050, and other product candidates. GTB-3550 is a TriKE comprised of two single-chain variable fragments (scFv) composed of the variable regions of the heavy and light chains of anti-CD16 and anti-CD33 antibodies and a modified form of IL-15. GTB-3650 is a TriKE which targets CD33 on the surface of myeloid leukemias. The Company also has a worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology.

Webull offers GT Biopharma Inc stock information, including NASDAQ: GTBP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GTBP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GTBP stock methods without spending real money on the virtual paper trading platform.